ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced esophageal cancer: combo therapies tested
Disease control CompletedThis study tested new drug combinations, with or without the immunotherapy pembrolizumab and chemotherapy, in 90 people with advanced esophageal cancer that had worsened after one prior treatment. The goal was to see if these combinations are safe and help shrink tumors or slow c…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New drug combo shows promise in slowing esophageal cancer
Disease control CompletedThis study tested whether adding the drug tislelizumab to standard chemoradiotherapy helps people with localized esophageal squamous cell carcinoma. 370 participants received either tislelizumab or a placebo alongside their cancer treatment. The main goal was to see if the drug c…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE3 • Sponsor: BeiGene • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Immunotherapy matches standard care in esophageal cancer study
Knowledge-focused CompletedThis study looked at 200 patients with advanced esophageal cancer to compare two treatments given before surgery: immunotherapy plus chemotherapy versus chemoradiotherapy. Both treatments led to similar long-term survival rates. The study suggests that immunotherapy may offer ext…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: NA • Sponsor: Yongtao Han • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC